111In-Pentetreotide Uptake Due to COVID-19 Vaccination. (6th March 2022)

• Record Type: Journal Article
• Authors: Koyasu, Sho; Nakamoto, Yuji
• Is Part Of: Clinical nuclear medicine. Volume 47:Number 3(2022)
• Page Start: 271
• Page End: 272
• Publication Date: 2022-03-06
• Subjects: 111In-pentetreotide -- COVID-19 -- deltoid muscle -- vaccine; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000003935
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract: A 72-year-old woman was referred for whole-body 111 In-pentetreotide scintigraphy with SPECT/CT. There was increased uptake of lymphadenopathy in the left axilla and left deltoid muscle. The patient's history revealed that the patient received the first dose of the COVID-19 vaccine 3 days before the 111 In-pentetreotide scintigraphy with SPECT/CT. This case demonstrates that the COVID-19 vaccine can cause 111 In-pentetreotide uptake in the lymph nodes and the deltoid muscle.